These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1464731

  • 1. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells.
    Zhou Z, Tenen DG, Dvorak AM, Ackerman SJ.
    J Leukoc Biol; 1992 Dec; 52(6):588-95. PubMed ID: 1464731
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
    Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ.
    Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
    [Abstract] [Full Text] [Related]

  • 3. Formation of Charcot-Leyden crystals by human basophils.
    Ackerman SJ, Weil GJ, Gleich GJ.
    J Exp Med; 1982 Jun 01; 155(6):1597-609. PubMed ID: 7042896
    [Abstract] [Full Text] [Related]

  • 4. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
    Dvorak AM, Furitsu T, Letourneau L, Ishizaka T, Ackerman SJ.
    Am J Pathol; 1991 Jan 01; 138(1):69-82. PubMed ID: 1987770
    [Abstract] [Full Text] [Related]

  • 5. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
    Dvorak AM, Ackerman SJ.
    Lab Invest; 1989 Apr 01; 60(4):557-67. PubMed ID: 2709814
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily.
    Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG.
    J Immunol; 1993 Jan 15; 150(2):456-68. PubMed ID: 8419478
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
    Leonidas DD, Elbert BL, Zhou Z, Leffler H, Ackerman SJ, Acharya KR.
    Structure; 1995 Dec 15; 3(12):1379-93. PubMed ID: 8747464
    [Abstract] [Full Text] [Related]

  • 8. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
    Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ.
    Clin Exp Allergy; 1997 Apr 15; 27(4):452-74. PubMed ID: 9146940
    [Abstract] [Full Text] [Related]

  • 9. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas.
    Dvorak AM, Letourneau L, Weller PF, Ackerman SJ.
    Lab Invest; 1990 May 15; 62(5):608-15. PubMed ID: 2160563
    [Abstract] [Full Text] [Related]

  • 10. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
    Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ.
    Lab Invest; 1990 May 15; 62(5):590-607. PubMed ID: 2160562
    [Abstract] [Full Text] [Related]

  • 11. Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.
    Grozdanovic MM, Doyle CB, Liu L, Maybruck BT, Kwatia MA, Thiyagarajan N, Acharya KR, Ackerman SJ.
    J Allergy Clin Immunol; 2020 Aug 15; 146(2):377-389.e10. PubMed ID: 31982451
    [Abstract] [Full Text] [Related]

  • 12. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion.
    Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR.
    J Biol Chem; 2002 Apr 26; 277(17):14859-68. PubMed ID: 11834744
    [Abstract] [Full Text] [Related]

  • 13. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils.
    Calafat J, Janssen H, Knol EF, Weller PF, Egesten A.
    Eur J Haematol; 1997 Jan 26; 58(1):56-66. PubMed ID: 9020375
    [Abstract] [Full Text] [Related]

  • 14. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals.
    Weller PF, Bach D, Austen KF.
    J Immunol; 1982 Mar 26; 128(3):1346-9. PubMed ID: 6173432
    [Abstract] [Full Text] [Related]

  • 15. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter.
    Gomolin HI, Yamaguchi Y, Paulpillai AV, Dvorak LA, Ackerman SJ, Tenen DG.
    Blood; 1993 Sep 15; 82(6):1868-74. PubMed ID: 8400237
    [Abstract] [Full Text] [Related]

  • 16. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
    Weller PF, Goetzl EJ, Austen KF.
    Proc Natl Acad Sci U S A; 1980 Dec 15; 77(12):7440-3. PubMed ID: 6261258
    [Abstract] [Full Text] [Related]

  • 17. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils.
    Golightly LM, Thomas LL, Dvorak AM, Ackerman SJ.
    J Leukoc Biol; 1992 Apr 15; 51(4):386-92. PubMed ID: 1373430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.